Inspiratory muscle training combined with positive expiratory pressure therapy

Inspiratory muscle training combined with positive expiratory pressure therapy has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Mar 6, 2026: “Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on inspiratory muscle training combined with positive expiratory pressure therapy

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“By 3 months, FEV1/FVC (p = 0.02), FEV1 (L and % predicted; p = 0.01 and p = 0.04), FVC (L and % predicted; p = 0.04), and MEF25–75% (p = 0.01) were higher”
Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patientsBMC pulmonary medicine2026doi:10.1186/s12890-025-04078-x

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1

Studies in people

1 study gave inspiratory muscle training combined with positive expiratory pressure therapy to people and measured what changed.

What changedDesignPeopleSource

up: Increases FEV1

up: Increases maximal inspiratory pressure

up: Improves six-minute walk test distance

Randomized trial3 months62 peopleStable Group E COPDBMC pulmonary medicine, Mar 6, 2026

What did studies of inspiratory muscle training combined with positive expiratory pressure therapy find?

4

Studies of inspiratory muscle training combined with positive expiratory pressure therapy measured 4 outcomes; the most studied are dyspnea (1 study), six-minute walk test distance (1) and maximal inspiratory pressure (1).

Dyspnea

downin humans1

1 study
  1. Inspiratory muscle training combined with positive expiratory pressure therapy decreases dyspnea in humans (stable Group E COPD).

    “MBS, mMRC, VAS, and CAT scores decreased (p < 0.001 for each).”

    Human trialstable Group E COPD3 monthsn = 62

    Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients

    BMC pulmonary medicine

Six-minute walk test distance

upin humans1

1 study
  1. Inspiratory muscle training combined with positive expiratory pressure therapy improves six-minute walk test distance in humans (stable Group E COPD).

    “SpO2 and 6MWT increased (both p < 0.001)”

    Human trialstable Group E COPD3 monthsn = 62

    Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients

    BMC pulmonary medicine

Maximal inspiratory pressure

upin humans1

1 study
  1. Inspiratory muscle training combined with positive expiratory pressure therapy increases maximal inspiratory pressure in humans (stable Group E COPD).

    “MIP increased in absolute and % predicted terms (p = 0.001 and p = 0.002), whereas MEP did not change significantly.”

    Human trialstable Group E COPD3 monthsn = 62

    Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients

    BMC pulmonary medicine

More on Maximal inspiratory pressure

FEV1

upin humans1

1 study
  1. Inspiratory muscle training combined with positive expiratory pressure therapy increases FEV1 in humans (stable Group E COPD).

    “By 3 months, FEV1/FVC (p = 0.02), FEV1 (L and % predicted; p = 0.01 and p = 0.04), FVC (L and % predicted; p = 0.04), and MEF25–75% (p = 0.01) were higher”

    Human trialstable Group E COPD3 monthsn = 62

    Effects of combined inspiratory muscle training and positive expiratory pressure therapy on pulmonary function, respiratory muscle strength, exercise capacity and dyspnea in stable group E COPD patients

    BMC pulmonary medicine

More on FEV1

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months